News
2024
10|18
AROMICS participates in BIOJAPAN
Aromics participated in BioJapan, the benchmark fair in the sector in Asia, held in Yokohama from 9 to 11th October. The company was one of the catalan companies of the catalan delegation headed by the BioRegion of...
read whole news
2024
10|18
The EU-Japan Biotech & Pharma Partnering Conference 2024
Aromics and our CEO Dr. Plasencia, presented latest advances of the company programs at the EU-Japan Biotech & Pharma Partnering Conference 2024 offers business contacts to industry professionals looking for potential partners in the Biotech and Pharma...
read whole news
2024
07|17
Aromics joins the working group of Chemical Exposomes at SOCSA
Our CEO, Dr. Carmen Plasencia, has joined the working group of Chemical Exposomes at SOCSA.
Among the objectives
To work on the study and updating of the chemical exposome.
To make the chemical exposome and its impact on health known to health...
read whole news
2024
07|17
Completed IDEA2 MIT program
7 months of intense mentoring from the world’s best at MIT: finished ✔
Our project has completed its participation in the IDEA2 MIT program. This incredible seven-month experience provided innovation training and project mentoring from renowned...
read whole news
2024
02|14
EEN2EIC Cross-sector e-pitch session
Our Ceo, Dr. Plasencia among the speakers selected for the EENC Cross-sector pitch event.
The EEN2EIC (Enterprise Europe Network to European Innovation Council) project aims to extend the breadth of supporting activities EEN can provide to women entrepreneurs,...
read whole news
2023
12|21
Aromics wishes you Merry Christmas and Happy New Year 2024
Wishing all of you Merry Christmas and Happy New Year.
read whole news
2023
12|22
AROMICS among the 8 companies selected by MIT IDEA2 program
MIT linQ, an international biomedical technology innovation consortium based in the Massachusetts Institute of Technology Institute for Medical Engineering and Sciences (MIT IMES), introduced the eight teams admitted to IDEA2 2024. The seven-month...
read whole news
2023
12|21
XII Pharma-Biotech collaboration event in Farmaindustria
Aromics and its project BERMES, among the 8 biotech companies selected for the XII forum of collaboration between Pharma and Biotech organized by FARMAINDUSTRIA in Madrid. The forum aims to improve the partnerships and collaborations among biotech and...
read whole news
2023
12|21
I Asbestos Meeting in Navarra
The main objective of this first congress in Navarra is to inform citizens about the danger that living with asbestos represents for everyone, as well as to urge the competent authorities to eradicate asbestos in our province and to create safe cemeteries...
read whole news
2023
10|26
36th ECNP Congress in Barcelona
The annual ECNP Congress is Europe’s premier scientific meeting for disease-oriented brain research, annually attracting more than 5,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world. Aromics is exploring...
read whole news
2023
10|24
CPHI Meeting Barcleona
AROMMICS will participate in CPHI meeting 2023 in Barcelona. It is among the most important meeting of pharmaceutical sector. We are looking forward to meeting pharma professionals, face-to-face, at the heart of pharma. CPHI unites the...
read whole news
2023
09|27
Biospain 2023
On September 26-28, 2023, BIOSPAIN will take place in Barcelona, one of the largest international biotechnology events in southern Europe, which will be carried out thanks to a coordinated collaboration with Biocat, the Government...
read whole news
2023
06|26
iMIG 2023
The International Mesothelioma Interest Group (iMig) and the French Cooperative Thoracic Intergroup (IFCT) organize the 16th International Conference of the international Mesothelioma interest group (iMig 2023) to be held on June 26th – 28th...
read whole news
2023
05|30
EXPOQUIMIA
The international chemical meeting Expoquimia brings together all chemical sectors in the same show to highlight the strategic importance of the transformation of the industry towards more energy-efficient production models and circular economy criteria....
read whole news
2023
03|09
1st Congress of Environmental Health and Medicine
Congress of Environmental Health and Medicine in Barcelona on April 21, 2023. Attend in person or online and participate with abstracts or photographs. The congress will address the current challenges in health and environment. Register now and take...
read whole news
2023
01|17
1st Multidisciplinary Meeting to address the problem of diseases of environmental origin
Next 26th and 27th January will take place the first multidisciplinary meeting to address the problem of diseases of environmental origin. The event, will take place on Hospital HM Nou Delfos, Auditorium D, Avinguda de Vallcarca,...
read whole news
2022
11|16
Convention against asbestos and its consequences
The collective of Macosa-Alstom Retirees Affected by Asbestos, together with the Federation of Neighborhood Associations of Barcelona, organized for November 26th, at the Auditorium Sant Martí, the first Convention against asbestos and its...
read whole news
2022
03|25
AROMICS - one of the winners of Chemostart V Edition Program
ChemoStart is a global programme which provides support for startups and companies designing innovative projects in the field of health and medical care.
he Insud Pharma group has announced the winners of the V edition of its ChemoStart...
read whole news
2021
11|24
Aromics one of the companies pitching at #EICSummit2021
The new European Innovation Council, launched in March 2021, is holding this event on 24-25 November 2021 in Brussels in an online format. It offers a unique opportunity for European start-ups, SMEs, researchers, potential investors, to connect and...
read whole news
2021
05|13
AROMICS among the top 40 companies to invest in Europe
InvestHorizon is a programme financed by the European Commission, in association with Eureka, to facilitate series A funding for selected deep tech companies boosting their investment readiness and investor relations. The programme is run by a consortium...
read whole news
2021
01|12
Aromics selected at the program of EIT Health investor network
As part of the strategy to attract investment for the clinical development of its products for the treatment of cancer, Aromics has been selected to be part of the European Institute of Technology (EIT) Health Investors Network, which will support the...
read whole news
2021
01|12
Our CEO, Dr Carmen Plasencia, second finalist at the EUTOP50 2020 awards in the Deep Technology category
Dr. Carmen Plasencia, CEO of AROMICS has been the second finalist in the prestigious EUTOP50 2020 award in the Deep Technology category, for her work at the forefront of biotechnology.
The award recognizes the efforts and contributions...
read whole news
2020
05|08
COVID information
In the context of the current global health crisis caused by COVID-19, Aromics remains open. It also reports that since the beginning of the COVID-19 pandemic, the company is executing the necessary contingency plans to guarantee the health and safety...
read whole news
2020
03|26
Asbestos, a health problem. How can we get it out of the buildings?
The Association of Technical Architects and Building Engineers of Barcelona (Caateeb), within its "Construction Dialogues" cycles, warned last Monday of the risk to public health posed by asbestos and the need for the Administration to...
read whole news
2020
03|26
Barça is hosting a meeting of female entrepreneurs and managers to explain the women's football project and promote the role of women in sport.
Futbol Club Barcelona hosts a meeting of female entrepreneurs and managers to explain the women's football project and to promote the role of women in sport. More than 70 businesswomen, amongst them our CEO Carme Plasencia and Catalan...
read whole news
2020
03|26
Aromics and its project Bermes in the exhibition "The fight against asbestos".
The TMB Foundation has organised an exhibition to explain the measures that the TMB company has taken to eliminate asbestos from the Barcelona metro, from which it has already removed 108.7 tonnes of this material potentially fatal to health.
The...
read whole news
2019
12|16
AROMICS wishes you Merry Christmas
AROMICS team wishes you Merry Christmas and Happy New Year.
The company will remain closed from 24th December 2019 until 2nd January 2020.
read whole news
2019
11|28
AROMICS selected at the accelerator program InvestHorizon
AROMICS is among the companies selected in the second edition of the InvestHorizon Acceleration Programme, which will host 55 companies in the next 4-6 months. InvestHorizon is an accelerator program designed to facilitate access to Series A financing...
read whole news
2019
11|14
Working day on asbestos and its impact in human health
On the 15th November 2019, the first scientific working session on asbestos and its consequences in health will take place. It is a scientific day aimed to discuss about different aspects of the diseases directly associated...
read whole news
2019
11|10
Aromics at 7th mRNA Health Conference in Berlin
Dr. Carme Plasencia, CEO of Aromics presented on 11-12 November the progress of the BERMES Project funded by the European Union's Horizon 2020 programme at the 7th International mRNA Health Conference.
The conference...
read whole news
2019
10|24
Aromics selected for the InvestHorizon Acceleration Programme
AROMICS is on the companies selected on the sеcond round of the InvestHorizon Acceleration Programme that will accommodate 55 companies within the next 4-6 months. InvestHorizon is an accelerator programme designed to facilitate the access...
read whole news
2019
09|30
AROMICS will be present at the Sino-Europe Innovation Week of Health Technology
Dr. Carmen Plasencia, CEO of AROMICS will attend next month (from 13.10.19 till 16.10.19) to the 2019 SIWHT, Sino-EU Innovation Week of Health Technology, taking place in the most innovative area of Shenzhen, Nanjing and Shanghai in China.
The...
read whole news
2019
09|25
2nd META-CAN Workshop
AROMICS is one of the participants of META-CAN, a multidisciplinary coordinated EU funded project that studies the involvement of metabolism and immune system in cancer in order to unveil new therapeutic targets.
2nd META-CAN Workshop was...
read whole news
2019
07|11
Aromics at LaBiotech Journal : Using ‘Omics’ to Develop Treatments for Drug-Resistant Cancer
Labiotech.eu, the leading digital media covering the European Biotech industry with over 150,000 monthly visitors, has selected AROMICS as one of the biotechs in Europe leading with OMIC technologies and its application to drug discovery and...
read whole news
2019
11|19
AROMICS' CEO present at the SME instrument Wellcome Day
AROMICS Chief Executive Officer and co-founder, Dr. Carmen Plasencia, was one participants in the event organized by the European Innovation Council (EIC) pilot dedicated to SME Phase 2 Insturment funded projects.
The company...
read whole news
2019
03|31
AROMICS renews the Seal for Innovative SMEs
The Spanish Ministry of Science, Innovation and Universities recognized the innovation and advances of Aromics in developing novel therapies for highly unmet medical needs. The seal awards companies that have proven, with its trajectory and activity,...
read whole news